Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Condensed Consolidated Interim Statements of Changes in Shareholders' Equity (Unaudited)

v3.10.0.1
Condensed Consolidated Interim Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Issued capital [member]
Reserve of share-based payments [member]
Share premium [member]
Accumulated other comprehensive income [member]
Retained earnings [member]
Total
Balance (in shares) at Dec. 31, 2016 15,722          
Balance at Dec. 31, 2016 $ 218,034 $ 7,306 $ 21,413 $ (4,298) $ (235,127) $ 7,328
Statement Line Items [Line Items]            
Common shares issued (in shares) 8,858          
Common shares issued $ 10,203 10,203
Stock-based compensation (note 7) 666 666
Expiry of vested stock options (1,487) 1,487
Net loss for the period (8,373) (8,373)
Common shares issued on redemption of restricted share units (note 7) (in shares) 150          
Common shares issued on redemption of restricted share units (note 7) $ 171 (171)
Balance (in shares) at Sep. 30, 2017 24,730          
Balance at Sep. 30, 2017 $ 228,408 6,314 22,900 (4,298) (243,500) 9,824
Balance (in shares) at Dec. 31, 2017 27,502          
Balance at Dec. 31, 2017 $ 231,923 6,456 22,909 (4,298) (246,788) 10,202
Statement Line Items [Line Items]            
Common shares issued (in shares) 2,017          
Common shares issued $ 6,818 6,818
Common shares issued pursuant to 2017 Share Purchase Agreement (note 6(a)(ii)) (in shares) 5,232          
Common shares issued pursuant to 2017 Share Purchase Agreement (note 6(a)(ii)) $ 14,995 14,995
Common shares issued pursuant to 2018 Share Purchase Agreement (note 6(a)(iii)) (in shares) 170          
Common shares issued pursuant to 2018 Share Purchase Agreement (note 6(a)(iii)) $ 600 600
Common shares issued upon exercise of stock options (note 7) (in shares) 96          
Common shares issued upon exercise of stock options (note 7) $ 379 (160) 219
Stock-based compensation (note 7) 3,695 3,695
Expiry of vested stock options (41) 41
Net loss for the period (22,604) (22,604)
Balance (in shares) at Sep. 30, 2018 35,017          
Balance at Sep. 30, 2018 $ 254,715 $ 9,950 $ 22,950 $ (4,298) $ (269,392) $ 13,925